FY2024 EPS Estimates for U.S. Physical Therapy, Inc. Reduced by Barrington Research (NYSE:USPH)

U.S. Physical Therapy, Inc. (NYSE:USPH) – Equities research analysts at Barrington Research decreased their FY2024 EPS estimates for shares of U.S. Physical Therapy in a research note issued on Wednesday, October 9th. Barrington Research analyst M. Petusky now forecasts that the company will post earnings per share of $2.20 for the year, down from their prior forecast of $2.30. Barrington Research currently has a “Outperform” rating and a $108.00 price target on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.47 per share. Barrington Research also issued estimates for U.S. Physical Therapy’s Q4 2024 earnings at $0.56 EPS, Q1 2025 earnings at $0.43 EPS, Q2 2025 earnings at $0.77 EPS, Q3 2025 earnings at $0.61 EPS and Q4 2025 earnings at $0.69 EPS.

Several other equities analysts have also recently commented on USPH. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. Bank of America restated a “neutral” rating and set a $90.00 price objective (down previously from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th.

U.S. Physical Therapy Stock Up 3.6 %

U.S. Physical Therapy stock opened at $80.32 on Thursday. The stock has a market cap of $1.21 billion, a price-to-earnings ratio of 75.77, a PEG ratio of 3.16 and a beta of 1.39. The company has a current ratio of 1.88, a quick ratio of 1.88 and a debt-to-equity ratio of 0.28. The company’s 50-day moving average price is $84.09 and its two-hundred day moving average price is $94.40. U.S. Physical Therapy has a 52 week low of $76.18 and a 52 week high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing the consensus estimate of $0.82 by ($0.09). The company had revenue of $167.19 million for the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.76 EPS.

Institutional Trading of U.S. Physical Therapy

Institutional investors have recently made changes to their positions in the stock. Silvercrest Asset Management Group LLC bought a new position in U.S. Physical Therapy during the first quarter valued at approximately $8,158,000. Renaissance Technologies LLC raised its position in U.S. Physical Therapy by 763.7% during the second quarter. Renaissance Technologies LLC now owns 69,523 shares of the company’s stock valued at $6,425,000 after acquiring an additional 61,474 shares in the last quarter. Norden Group LLC raised its position in U.S. Physical Therapy by 1,841.6% during the first quarter. Norden Group LLC now owns 63,938 shares of the company’s stock valued at $7,217,000 after acquiring an additional 60,645 shares in the last quarter. Vanguard Group Inc. raised its position in shares of U.S. Physical Therapy by 2.5% in the fourth quarter. Vanguard Group Inc. now owns 1,062,427 shares of the company’s stock valued at $98,954,000 after purchasing an additional 26,224 shares during the period. Finally, Dimensional Fund Advisors LP raised its position in shares of U.S. Physical Therapy by 2.5% in the second quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock valued at $39,173,000 after purchasing an additional 10,462 shares during the period.

Insider Activity

In other news, Director Kathleen A. Gilmartin bought 2,000 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The stock was bought at an average cost of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the acquisition, the director now directly owns 18,904 shares in the company, valued at $1,627,445.36. This represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, Director Kathleen A. Gilmartin purchased 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was acquired at an average cost of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the acquisition, the director now owns 18,904 shares in the company, valued at $1,627,445.36. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Graham D. Reeve sold 1,724 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total transaction of $142,230.00. Following the sale, the chief operating officer now owns 7,038 shares of the company’s stock, valued at approximately $580,635. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Friday, August 23rd were given a dividend of $0.44 per share. The ex-dividend date of this dividend was Friday, August 23rd. This represents a $1.76 annualized dividend and a dividend yield of 2.19%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 166.04%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.